The effect of dexmedomidine and remifentanil on pain during gynecological laparoscopic surgery

Effect of Dexmedetomidine-Remifentanil Infusion on Pain during Gynecologic Laparoscopy

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20110712007013N24

Enrollment

Registered

2019-12-19

Start date

2019-12-22

Completion date

Unknown

Last updated

2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute postoperative pain. Acute Pain

Interventions

Intervention 1: Intervention group:In this group 0.5mg / kg dexmedomidine and 1mg/kg remifentanil in 10 ml normal 0.9% saline solution started within starting 10 minutes of surgery and dexmedomidine 0

Eligibility

Sex/Gender

Female

Age

18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Female patients with ASA class I&II aged 18-60 years

Exclusion criteria

Exclusion criteria: Patients with cardiovascular, pulmonary, liver and kidney and ...disease Sensitivity to the studied compounds History of chronic pain and long-term use of pain medications for more than three months

Design outcomes

Primary

Measure	Time frame
Pain. Timepoint: PACU and at 1, 3, 6, 12 and 24h after surgery. Method of measurement: visual analogue scale(VAS) (0= non to 10= severe pain).	—

Secondary

Measure	Time frame
Overall dose of postoperative analgesic. Timepoint: PACU and during 24h postoperatively. Method of measurement: number and amount of medication by mg.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Simin Atashkhoyi

Tabriz University of Medical Sciences

satashkhoyi@gmail.com+98 41 3553 9161

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026